Condition
Endolymphatic Hydrops
Total Trials
5
Recruiting
1
Active
1
Completed
1
Success Rate
33.3%-53% vs avg
Key Insights
Highlights
Success Rate
33% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
40.0%
2 terminated out of 5 trials
Success Rate
33.3%
-53.2% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
33% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Terminated2
Recruiting1
Withdrawn1
Completed1
Trial Success Rate
33.3%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05229744TerminatedPrimary
Prevalence of Endolymphatic Hydrops With a Hitory of Congenital Cytomegalovirus Infection
NCT06910865RecruitingPrimary
Study of the Radio-clinical Correlation of Endolymphatic Hydrops
NCT03215420Not ApplicableCompletedPrimary
Comparison of 3 Methods to Diagnose Endolymphatic Hydrops in Meniere's Disease
NCT03132961Terminated
Effects of Infrasound Exposure on Measures of Endolymphatic Hydrops
NCT01661777Not ApplicableWithdrawn
Refractory Eustachian Tube Dysfunction: Are the Symptoms Related to Endolymphatic Hydrops
Showing all 5 trials